Clinical Trials Browser

HER2-negative Breast Cancer × Epirubicin × Clear all

NCT04576143 2021-08-12

Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer

Phase 2/3 Recruiting

HER2-negative Breast Cancer

NCT04498793 2020-09-03

Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer

Phase 2 Unknown

HER2-negative Breast Cancer